The system also introduces Imaging Scanner Interface 2 (ISI2) capability, enabling direct communication between injector and scanner to improve exam coordination and operational efficiency
The new subcutaneous autoinjector for lecanemab offers a self-administered, at-home treatment option for early-stage Alzheimer's disease
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The approval was driven by data from the Phase III TULIP-SC trial
The trial also demonstrated significant improvements across multiple secondary endpoints
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
Subscribe To Our Newsletter & Stay Updated
